Chemoenzymatic glycan editing for deciphering biological functions of glycans

化学酶聚糖编辑破译聚糖的生物学功能

基本信息

  • 批准号:
    10799053
  • 负责人:
  • 金额:
    $ 14.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-02-01 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Cell-surface glycans participate in numerous biological processes, including signal transduction, cell-cell communication and development. Aberrant glycosylation is a hallmark of human disease. At a molecular level, glycans represent the first points of contact between cells. However, not directly encoded in the genome, these biomolecules are challenging to study using molecular biology techniques alone. Metabolic oligosaccharide engineering (MOE) developed in late 1990’s has revolutionized the way for the labeling and visualization of glycans in living organisms. In this method, cells’ own glycan biosynthetic machinery is hijacked to incorporate unnatural monosaccharides with linkage promiscuity. Complementary to MOE, chemoenzymatic glycan editing has emerged as a valuable tool to probe and modify glycan structures within a cellular environment. Unlike MOE, chemoenzymatic glycan modification utilizes recombinant glycosyltransferases to transfer natural or unnatural monosaccharides with novel functions from activated nucleotide sugars to glycoconjugates on the cell surface with linkage specificity. For these reasons, chemoenzymatic glycan modification provides a facile and more precise way for probing the function of glycans in their native environments. Building upon our successful application of chemoenzymatic glycan editing, in the next five years we will expand our chemoenzymatic tool kits to study glycans’ cellular functions with a focus on the special roles of N- acetyllactosamine (LacNAc), fucose and sialic acid in immune regulation. Cell-surface LacNAc mediates ligand-receptor binding and sets a threshold for initiating the downstream signaling for immune cell activation. LacNAc residues are dynamically modified by sialic acid and/or fucose. However, the specific roles of these modifications in immune regulation and disease progression remain obscure. We are particularly interested in finding out: (1) if changes in LacNAc and fucosylation status can serve as glycan signatures of T cell exhaustion during which T cells gradually lose their cytokine production, proliferation and cytotoxic capacity; (2) Can cell-surface in situ LacNAc fucosylation be used to boost the efficacy of antitumor immunity of T cells and NK cells? In parallel, we will develop chemoenzymatic tools for profiling sialylated glycoprotein ligands of Siglecs (sialic acid-binding immunoglobulin-type lectins) and for the identification of unnatural, high-affinity and specific ligands to interrogate Siglec functions. Through these studies, we will gain a deeper understanding of how LacNAc, fucose and sialic acid are involved in the regulation of the immune cell activation, effector function and exhaustion. Tools developed in this project can also be used to study other types of glycans and their interactions with glycan binding proteins.
项目总结/文摘

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell Lymphoma.
  • DOI:
    10.3389/fimmu.2022.904693
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peng Wu其他文献

Peng Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peng Wu', 18)}}的其他基金

Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10555320
  • 财政年份:
    2021
  • 资助金额:
    $ 14.61万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10297728
  • 财政年份:
    2021
  • 资助金额:
    $ 14.61万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10621946
  • 财政年份:
    2021
  • 资助金额:
    $ 14.61万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10417251
  • 财政年份:
    2021
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10329937
  • 财政年份:
    2021
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemical Tools for Studying Fucosylated Glycans
用于研究岩藻糖基化聚糖的化学工具
  • 批准号:
    9320789
  • 财政年份:
    2016
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemical Tools for Studying Fucosylated Glycans
用于研究岩藻糖基化聚糖的化学工具
  • 批准号:
    9105947
  • 财政年份:
    2016
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemoenzymatic methods for the detection of cell-surface glycans
检测细胞表面聚糖的化学酶法
  • 批准号:
    8964803
  • 财政年份:
    2015
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemical tools for studying fucosylated glycans
研究岩藻糖基化聚糖的化学工具
  • 批准号:
    8535787
  • 财政年份:
    2010
  • 资助金额:
    $ 14.61万
  • 项目类别:
Chemical tools for studying fucosylated glycans
研究岩藻糖基化聚糖的化学工具
  • 批准号:
    8326225
  • 财政年份:
    2010
  • 资助金额:
    $ 14.61万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
    Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 14.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了